Michel Clanet

Michel Clanet

UNVERIFIED PROFILE

Are you Michel Clanet?   Register this Author

Register author
Michel Clanet

Michel Clanet

Publications by authors named "Michel Clanet"

Are you Michel Clanet?   Register this Author

47Publications

1493Reads

10Profile Views

Cervical dysplasia in a patient with multiple sclerosis treated with natalizumab.

Fundam Clin Pharmacol 2019 Feb 12;33(1):125-126. Epub 2018 Jul 12.

Service de Pharmacologie Médicale et Clinique, Centre Midi-Pyrénées de PharmacoVigilance, de Pharmacoépidémiologie et d'Informations sur le Médicament, Pharmacopôle Midi-Pyrénées, INSERM, UMR 1027, CIC INSERM 1436, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/fcp.12394DOI Listing
February 2019

Late-onset neutropenia and neurological relapse, during long-term rituximab therapy in myelin oligodendrocyte glycoprotein-antibody spectrum disorder.

Mult Scler 2018 10 9;24(12):1645-1647. Epub 2018 May 9.

Pole des Neurosciences, Unité de neurologie, Hôpital Pierre-Paul Riquet, CHU Purpan, Toulouse, France; INSERM UMR 1043, Université Toulouse III, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458518765677DOI Listing
October 2018

ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis.

Mult Scler 2018 02 20;24(2):96-120. Epub 2018 Jan 20.

Department of Neurology, Focus Program Translational Neuroscience (FTN) and Immunology (FZI), Rhine-Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458517751049DOI Listing
February 2018

Assessment of a program to encourage the multidisciplinary management of urinary disorders in multiple sclerosis.

Neurourol Urodyn 2017 03 29;36(3):706-709. Epub 2016 Mar 29.

Service de médecine physique et réadaptation, CHU Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/nau.23002DOI Listing
March 2017

Risk of relapse after natalizumab withdrawal: Results from the French TYSEDMUS cohort.

Neurol Neuroimmunol Neuroinflamm 2016 Dec 28;3(6):e297. Epub 2016 Oct 28.

Neurology Department (C.P., S.M., C.L.), Pitié-Salpêtrière Hospital, Paris; Service de Neurologie A, Hôpital Neurologique Pierre Wertheimer (S.V., C.C.), and Neuro-epidemiology and Pharmaco-epidemiology (E.V.G.), Hospices Civils de Lyon, Lyon/Bron; Centre des Neurosciences de Lyon (S.V., C.C.), INSERM 1028 et CNRS UMR5292, Equipe Neuro-oncologie et Neuro-inflammation; Université de Lyon (S.V., C.C.); Observatoire Français de la Sclérose en Plaques (R.C., N.D., Z.U.), Bron; Neurology Department (B.S.), Saint Antoine Hospital, Paris; Agence Nationale de Sécurité des Médicaments (ANSM, formerly Agence Française de Sécurité Sanitaire des Produits de Santé-AFSSAPS) (A.C.), Saint-Denis; and Neurology Department (M.C.), Purpan Hospital, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000297DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087255PMC
December 2016

Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients.

Neurology 2016 Nov 12;87(19):1985-1992. Epub 2016 Oct 12.

From Queen Mary University of London (G.G.), Barts and The London School of Medicine, UK; Mellen Center (J.A.C.), Cleveland Clinic, OH; Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Heinrich-Heine University, Düsseldorf, Germany; Department of Neurology and Center for Clinical Neuroscience (E.H.), First Medical Faculty, Charles University in Prague, Czech Republic; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; Sanofi Genzyme (D.H.M., S.L.L., M.A.P.), Cambridge, MA; and Evidence Scientific Solutions (S.M.K.), Philadelphia, PA (at the time the work was conducted).

View Article

Download full-text PDF

Source
http://www.neurology.org/lookup/doi/10.1212/WNL.000000000000
Publisher Site
http://dx.doi.org/10.1212/WNL.0000000000003319DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109953PMC
November 2016

Fingolimod treatment after natalizumab-related progressive multifocal leukoencephalopathy: three new cases.

Mult Scler 2015 Apr 10;21(5):671-2. Epub 2014 Oct 10.

Pole des neurosciences CHU Toulouse, France INSERM UMR 1043 et Université de Toulouse; UPS; France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458514549823DOI Listing
April 2015

Adult-onset genetic leukoencephalopathies: a MRI pattern-based approach in a comprehensive study of 154 patients.

Brain 2015 Feb 19;138(Pt 2):284-92. Epub 2014 Dec 19.

1 Département de Neurologie, CHU de Montpellier, 34295 Montpellier, France

View Article

Download full-text PDF

Source
http://brain.oxfordjournals.org/content/brain/138/2/284.full
Web Search
http://www.brain.oxfordjournals.org/cgi/doi/10.1093/brain/aw
Publisher Site
http://dx.doi.org/10.1093/brain/awu353DOI Listing
February 2015

Risk evaluation and monitoring in multiple sclerosis therapeutics.

Mult Scler 2014 Sep 30;20(10):1306-11. Epub 2013 Nov 30.

Scientific and Clinical Review Associates LLC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458513513207DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232326PMC
September 2014

A central nervous system B-cell lymphoma arising two years after initial diagnosis of CLIPPERS.

J Neurol Sci 2014 Sep 18;344(1-2):224-6. Epub 2014 Jun 18.

Pole des Neurosciences and INSERM UMR1043, Université Toulouse III, CHU Toulouse, Hôpital Purpan, Place du Docteur Baylac, 31059 Toulouse cedex 9, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2014.06.015DOI Listing
September 2014

Defining the clinical course of multiple sclerosis: the 2013 revisions.

Neurology 2014 Jul 28;83(3):278-86. Epub 2014 May 28.

From the Corinne Goldsmith Dickenson Center for Multiple Sclerosis (F.D.L., A.E.M.), Icahn School of Medicine at Mount Sinai, New York, NY; Scientific and Clinical Review Associates, LLC (S.C.R.), Salisbury, CT; The Mellen Center for MS Treatment and Research (J.A.C., R.J.F., R.A.R.), Cleveland Clinic, OH; the Department of Biostatistics (G.R.C.), University of Alabama at Birmingham; the Danish Multiple Sclerosis Center (P.S.S.), Department of Neurology, Copenhagen University Hospital Rigshospitalet, Denmark; University College London Institute of Neurology (A.J.T.), UK; the Department of Neurology (J.S.W., J.A.L.), University of Texas Health Sciences Center, Houston; the Department of Neurology (L.J.B.), New York University Langone Medical Center, New York; the Division of Neurology (B. Banwell), The Children's Hospital of Philadelphia, PA; the Departments of Radiology and Nuclear Medicine (F.B.) and Neurology (C.H.P.), VU Medical Center, Amsterdam, the Netherlands; Research Programs Department (B. Bebo), National Multiple Sclerosis Society, New York, NY; the Department of Neurology (P.A.C.), The Johns Hopkins Hospital, Baltimore, MD; Fédération de Neurologie (M.C.), CHU Hôpital Purpan, Toulouse, France; the Department of Neurology (G.C.), Scientific Institute San Raffaele, University Vita-Salute San Raffaele, Milan, Italy; University of Ottawa and the Ottawa Hospital Research Institute (M.S.F.), Canada; the Department of Neurology (A.D.G.), University of Rochester Medical Center, NY; the Departments of Neurology, Radiology and Neuroscience (M.I.), Mount Sinai School of Medicine, New York, NY; the Department of Neurology (L.K.), University Hospital, Basel, Switzerland; the Department of Neurology (B.C.K.), Heinrich-Heine-University, Düsseldorf, Germany; the Department of Neurology (C.L.), Salpêtrière Hospital, UPMC, Paris, France; the Department of Neurology-Neuroimmunology (X.M.), Cemcat, Hospital Universitari Vall d'Hebron, Barcelona, Spain; the Division of

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000000560DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117366PMC
July 2014

A case report of simultaneous PML-IRIS during corticosteroids tapering in a patient with an anti-synthetase syndrome.

F1000Res 2013 23;2:283. Epub 2013 Dec 23.

INSERM UMR 1043, Centre de Physiopathologie, Toulouse-Purpan, France ; Université Toulouse III, Toulouse F-31000, France ; Department of Neurology, Toulouse University Hospital, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12688/f1000research.2-283.v1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968897PMC
April 2014

Christian Confavreux (1949 - 2013).

Mult Scler 2013 Dec;19(14):1811-2

Department of Neurology, Mayo Clinic, Rochester, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458513512239DOI Listing
December 2013

Prospective evaluation of laparoscopic assisted cystectomy and ileal conduit in advanced multiple sclerosis.

Urology 2012 Oct 29;80(4):852-7. Epub 2012 Aug 29.

Département d'Urologie, Transplantation Rénale et Andrologie, CHU Rangueil, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2012.06.039DOI Listing
October 2012

Relevance of the skewness index in DTI exploration of multiple sclerosis.

MAGMA 2009 Apr 8;22(2):89-100. Epub 2008 Nov 8.

Department of Biophysics, University Hospital of Rangueil, 31059 Toulouse, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10334-008-0149-8
Publisher Site
http://dx.doi.org/10.1007/s10334-008-0149-8DOI Listing
April 2009

Mast cell transcripts are increased within and outside multiple sclerosis lesions.

J Neuroimmunol 2008 Mar 28;195(1-2):176-85. Epub 2008 Mar 28.

Institut National de la Santé et de la Recherche Médicale U563, Purpan Hospital, Place Dr Baylac, Toulouse 3100, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2008.01.017DOI Listing
March 2008

Thymic output and peripheral T lymphocyte subsets in relapsing--remitting multiple sclerosis patients treated or not by IFN-beta.

J Neuroimmunol 2008 Jan;193(1-2):188-94

Laboratoire d'Immunogénétique Moléculaire, Université Paul Sabatier, Faculté de médecine Toulouse-Rangueil, Bâtiment A2, 133 Route de Narbonne, 31062 Toulouse cedex 4, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2007.10.027DOI Listing
January 2008

Motivating MS patients: the Annual Convention 2005 of the MS Forum, 22 May 2005, St Julians, Malta.

Authors:
Michel Clanet

Int MS J 2005 Nov;12(3):109

View Article

Download full-text PDF

Source
November 2005

Diffusion tensor imaging in multiple sclerosis: a tool for monitoring changes in normal-appearing white matter.

Mult Scler 2004 Apr;10(2):188-96

Department of Biophysics and Multimodality Imaging, University Paul Sabatier, Toulouse-Rangueil, France.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1191/1352458504ms997oa
Publisher Site
http://dx.doi.org/10.1191/1352458504ms997oaDOI Listing
April 2004

Genetic analysis of multiple sclerosis in Europeans: French data.

J Neuroimmunol 2003 Oct;143(1-2):74-8

Laboratoire d'Immunologie, UPRES EA 1257 (IFR97), Faculté de Médecine, 2 Avenue du Pr Léon Bernard CS 34317, 35043 Rennes Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2003.08.015DOI Listing
October 2003